Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Share Price
$268.54
Market Cap
$647.15B
Change (1 day)
-0.37%
Change (1 year)
52.08%
Country
US
Trade Johnson & Johnson (JNJ)

Category

P/E ratio for Johnson & Johnson (JNJ)
P/E ratio as of September 2026 TTM: 30.79
According to Johnson & Johnson latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.79. At the end of 2024 the company had a P/E ratio of 24.53.
P/E ratio history for Johnson & Johnson from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 30.79 64.20%
2025 18.75 -23.56%
2024 24.53 117.16%
2023 11.30 -47.70%
2022 21.60 -22.85%
2021 28.00 10.67%
2019 25.30 12.64%
2018 22.46 -92.21%
2017 288.31 1,504.75%
2016 17.97 0.04%
2014 17.96 -4.59%
2013 18.82 4.89%
2012 17.95 39.12%
2011 12.90 -11.36%
2010 14.55 15.26%
2008 12.63 -30.55%
2007 18.18 3.55%
2006 17.56 -23.07%
2005 22.82 7.99%
2003 21.14 -13.54%
2002 24.45 -22.65%
2001 31.60 -0.45%
2000 31.75 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
38.12 23.80%
US
73.73 139.47%
US
22.25 -27.74%
CH
114.95 273.36%
US
22.23 -27.78%
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.